Jinyu Bio-technology Co., Ltd. (SHA:600201)
China · Delayed Price · Currency is CNY 8.77
+0.22 (2.57%)
Jul 25, 2025, 2:45 PM CST
Jinyu Bio-technology Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Operating Revenue | 1,229 | 1,225 | 1,508 | 1,485 | 1,754 | 1,567 | Upgrade |
Other Revenue | 30.13 | 30.13 | 89.92 | 43.97 | 22.64 | 14.59 | Upgrade |
| 1,259 | 1,255 | 1,598 | 1,529 | 1,776 | 1,582 | Upgrade | |
Revenue Growth (YoY) | -20.41% | -21.45% | 4.55% | -13.94% | 12.29% | 40.39% | Upgrade |
Cost of Revenue | 620.66 | 597.17 | 668.1 | 697.3 | 688.81 | 621.66 | Upgrade |
Gross Profit | 638.47 | 658.29 | 930.13 | 831.37 | 1,088 | 960.25 | Upgrade |
Selling, General & Admin | 451.19 | 432.34 | 491.55 | 421.77 | 501.9 | 400.14 | Upgrade |
Research & Development | 145.03 | 136.82 | 143.47 | 133.78 | 165.94 | 130.83 | Upgrade |
Other Operating Expenses | 26.94 | 21.83 | 23.14 | 22.26 | 24.5 | 23.24 | Upgrade |
Operating Expenses | 656.16 | 621.1 | 681.43 | 579.36 | 693.32 | 553.26 | Upgrade |
Operating Income | -17.68 | 37.19 | 248.7 | 252.01 | 394.19 | 406.99 | Upgrade |
Interest Expense | -5.91 | -5.5 | -0.05 | -4.81 | -0.04 | -0.97 | Upgrade |
Interest & Investment Income | 67.54 | 55.36 | 56.52 | 50.91 | 47.57 | 45.06 | Upgrade |
Currency Exchange Gain (Loss) | 0.05 | 0.05 | -0.02 | 0.08 | -0.05 | -0.21 | Upgrade |
Other Non Operating Income (Expenses) | -0.49 | -0.58 | 0.15 | 0.21 | -0.76 | -1.89 | Upgrade |
EBT Excluding Unusual Items | 43.51 | 86.52 | 305.28 | 298.39 | 440.91 | 448.97 | Upgrade |
Impairment of Goodwill | -3.21 | -3.21 | -18.08 | -65.02 | -39.75 | - | Upgrade |
Gain (Loss) on Sale of Investments | -9.63 | -9.49 | -7.78 | -9.81 | -3.22 | 8.48 | Upgrade |
Gain (Loss) on Sale of Assets | 2.41 | 2.58 | -0.04 | -0.04 | -2.31 | 0.04 | Upgrade |
Asset Writedown | -6.11 | -11.11 | -5.34 | -1.54 | -1.99 | -0.4 | Upgrade |
Other Unusual Items | 70.36 | 59.63 | 41.78 | 23.61 | 19.65 | 19.12 | Upgrade |
Pretax Income | 97.31 | 124.91 | 315.83 | 245.58 | 413.27 | 476.21 | Upgrade |
Income Tax Expense | 22.49 | 20.76 | 38.73 | 45.46 | 24.27 | 53.82 | Upgrade |
Earnings From Continuing Operations | 74.83 | 104.15 | 277.1 | 200.12 | 389.01 | 422.39 | Upgrade |
Minority Interest in Earnings | 5.05 | 4.83 | 6.53 | 10.54 | -6.72 | -16.19 | Upgrade |
Net Income | 79.88 | 108.99 | 283.63 | 210.66 | 382.29 | 406.2 | Upgrade |
Net Income to Common | 79.88 | 108.99 | 283.63 | 210.66 | 382.29 | 406.2 | Upgrade |
Net Income Growth | -71.73% | -61.58% | 34.64% | -44.90% | -5.89% | 83.76% | Upgrade |
Shares Outstanding (Basic) | 1,099 | 1,090 | 1,091 | 1,109 | 1,124 | 1,128 | Upgrade |
Shares Outstanding (Diluted) | 1,099 | 1,090 | 1,091 | 1,109 | 1,124 | 1,128 | Upgrade |
Shares Change (YoY) | 1.01% | -0.10% | -1.61% | -1.39% | -0.35% | 2.09% | Upgrade |
EPS (Basic) | 0.07 | 0.10 | 0.26 | 0.19 | 0.34 | 0.36 | Upgrade |
EPS (Diluted) | 0.07 | 0.10 | 0.26 | 0.19 | 0.34 | 0.36 | Upgrade |
EPS Growth | -72.01% | -61.54% | 36.84% | -44.12% | -5.56% | 80.00% | Upgrade |
Free Cash Flow | 202.63 | 199.89 | 141.67 | 154.54 | 160.4 | 471.3 | Upgrade |
Free Cash Flow Per Share | 0.18 | 0.18 | 0.13 | 0.14 | 0.14 | 0.42 | Upgrade |
Dividend Per Share | 0.030 | 0.030 | 0.080 | 0.060 | 0.110 | 0.120 | Upgrade |
Dividend Growth | -62.50% | -62.50% | 33.33% | -45.45% | -8.33% | 100.00% | Upgrade |
Gross Margin | 50.71% | 52.43% | 58.20% | 54.38% | 61.22% | 60.70% | Upgrade |
Operating Margin | -1.41% | 2.96% | 15.56% | 16.49% | 22.19% | 25.73% | Upgrade |
Profit Margin | 6.34% | 8.68% | 17.75% | 13.78% | 21.52% | 25.68% | Upgrade |
Free Cash Flow Margin | 16.09% | 15.92% | 8.86% | 10.11% | 9.03% | 29.79% | Upgrade |
EBITDA | 196.97 | 246.61 | 437.17 | 450.92 | 585.17 | 580.63 | Upgrade |
EBITDA Margin | 15.64% | 19.64% | 27.35% | 29.50% | 32.94% | 36.70% | Upgrade |
D&A For EBITDA | 214.65 | 209.42 | 188.47 | 198.91 | 190.98 | 173.64 | Upgrade |
EBIT | -17.68 | 37.19 | 248.7 | 252.01 | 394.19 | 406.99 | Upgrade |
EBIT Margin | -1.40% | 2.96% | 15.56% | 16.48% | 22.19% | 25.73% | Upgrade |
Effective Tax Rate | 23.11% | 16.62% | 12.26% | 18.51% | 5.87% | 11.30% | Upgrade |
Revenue as Reported | 1,259 | 1,255 | 1,598 | 1,529 | 1,776 | 1,582 | Upgrade |
Advertising Expenses | - | 162.42 | 179.06 | 166.38 | 241.94 | 172.68 | Upgrade |
Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.